Is Transvaginal Mesh Phase Out Appropriate Response?
In the wake of thousands of patient complications, the maker of a surgical mesh used to treat women’s pelvic organ prolapse (POP) and stress urinary incontinence (SUI), Johnson & Johnson, decided earlier this summer to phase out four mesh products between September 2012 and early 2013. However with as many as 75,000 patients undergoing a transvaginal mesh operation in 2011 alone, some observers are asking whether this gradual phase-out is too slow a course of action.
Just how common are transvaginal mesh complications? According to the Food and Drug Administration (FDA), as many as 10 percent of transvaginal mesh patients experience complications within a year of the mesh implantation surgery. A majority of these patients were secondary surgeries – and in some cases, even more follow medical procedures.
Have you experienced discomfort, pain, and medical expense as a result of your transvaginal mesh operation? Is a product liability suit right for you and your family? The experienced and dedicated attorneys at the Dallas law firm of Fears Nachawati are prepared to give you the advice you need about this important area of the law. Contact us today for your free consultation. Just call us at 1.866.545.8364 or email email@example.com. We’re ready to fight for you!